glutathione glioblastoma Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in Glioblastoma metabolomics: uncovering biomarkers for
Glioblastoma metabolomics: uncovering biomarkers for diagnosis, prognosis and targeted therapy Journal of Experimental & Clinical Cancer Research Springer Nature Link Mitochondrial Metabolic Reprogramming along with NRF2 KEAP1 Mediated Antioxidant Mechanisms Drive Temozolomide Resistance in Glioblastoma Multiforme Journal of Proteome Research Combined metformin and simvastatin therapy inhibits SREBP2 maturation and alters energy metabolism in glioma Cell Death & Disease Glioblastoma at the crossroads: current understanding and future therapeutic horizons Signal Transduction and Targeted Therapy
Pay in 4 interest-free payments of $7.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



